Increased Use of Recommended Drugs Explains Improved Trends in Prognosis after Myocardial Infarction
Soko Setoguchi
Douglas Zipes
SOKO SETOGUCHI, Brigham And Women’s Hospital, Boston
COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis
REFERENCE: Abstract 1018-148, American College of Cardiology New Orleans
The increased adherence to recommendations and guidelines for drug therapy after myocardial infarction during the last ten years has led to hoped-for improvements in outcomes and prognosis among patients treated. This is the finding of a study presented to the ACC meeting in New Orleans by Soko Setoguchi who discussed her group’s findings with Peter Goodwin.
[audio:https://www.audiomedica.com/podcasting/cardio/acc2007/070326_soko_setoguchi_zipes.mp3]The increased adherence to recommendations and guidelines for drug therapy after myocardial infarction during the last ten years has led to hoped-for improvements in outcomes and prognosis among patients treated. This is the finding of a study presented to the ACC meeting in New Orleans by Soko Setoguchi who discussed her group’s findings with Peter Goodwin.
